From Academic to Community: Practical Lessons in Establishing Radiopharmaceutical Therapy Programs
Tuesday, June 23, 2026 | 12:00 pm ET
Sponsored by Community Based Nuclear Medicine Committee
Organizer(s)/Moderator(s):
Calvin Huntzinger
Speaker(s):
Dustin Osborne, PhD, DABSNM, DABR, University of Tennessee Medical Center
Taylor Gillespie, BS, CNMT, University of Tennessee Medical Center
Course Summary
While numerous guidelines exist for establishing radiopharmaceutical therapy (RPT) programs, this webinar moves beyond the theoretical 'what' and 'why' to address the practical realities of implementation in community hospital settings. Drawing from real-world experience with the Appalachian Radiotheranostics Coalition (ARC), an SNMMI Mars Shot funded initiative spanning the Tennessee-North Carolina-Virginia corridor, this session will focus on actionable insights from teams who have successfully navigated the challenges of bringing theranostics to rural and underserved communities.
Course Objectives
Upon completion of this session, participants will be able to:
1. Identify the top three operational challenges encountered when establishing RPT programs in community hospitals and describe evidence-based mitigation strategies for each.
2. Explain how staffing roles and responsibilities evolve throughout RPT program development, from initial planning through established operations, including appropriate scope of practice for technologists, physicists, and nursing staff.
3. Apply financial planning principles specific to community-based RPT services, including realistic cost projections, revenue cycle considerations, and sustainability strategies beyond the initial implementation phase.
4. Evaluate site-specific factors that influence RPT program design and determine which best practices are universally applicable versus those requiring adaptation to local contexts.
CE Information:
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.